Brentuximab vedotin with Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma: A Children’s Oncology Group, Single-arm, Phase 1 / 2 Trial.

BACKGROUND: Patients with primary refractory Hodgkin lymphoma or early relapse have a poor prognosis. Although many salvage regimens have been developed, there is no standard of care. METHODS. Children’s Oncology Group protocol AHOD1221 (NCT01780662) tested Brentuximab vedotin with gemcitabine in ch...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet Oncol
Main Authors: Cole, Peter D., McCarten, Kathleen M., Pei, Qinglin, Spira, Menachem, Metzger, Monika L., Drachtman, Richard A., Horton, Terzah M., Bush, Rizvan, Blaney, Susan M., Weigel, Brenda J., Kelly, Kara M.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487196/
https://ncbi.nlm.nih.gov/pubmed/30122620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(18)30426-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares